Desmoid: Clinical Trials

4 trials for Desmoid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Active not recruiting 1, Recruiting 1
Phase 11Recruiting 1
Phase 31Active not recruiting 1

Follow Desmoid: new trials by email Literature Review of Desmoid trials Research Report on Desmoid

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer
Phase 1 / Phase 2RecruitingParabilis Medicines, Inc.6192023-05-232026-10-07
A Study of AL102 in Patients With Progressing Desmoid Tumors
AL102, Placebo - Desmoid, Desmoid Tumor
Phase 2 / Phase 3Active not recruitingImmunome, Inc.1982021-09-012026-06-08
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Drug Eluting Bead Embolization (DEB) for Desmoid Fibromatosis - Desmoid, Desmoid Fibromatosis of Skin
Phase 2CompletedRabin Medical Center82018-10-112022-03-25
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
nab paclitaxel - Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood
Phase 2CompletedGrupo Espanol de Investigacion en Sarcomas692017-05-092022-06-07

Narrower conditions

Desmoid Tumors (4)  ·  Neoplasms (2)  ·  Adenomatous Polyposis Coli (1)  ·  Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Craniopharyngioma (1)  ·  Desmoid disease, hereditary (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Endometrial Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Fibroma (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Connective Tissue (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Neoplasms, Fibrous Tissue (4)  ·  Neoplasms (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Adenocarcinoma (1)  ·  Adenoma (1)  ·  Adenomatous Polyps (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)

Interventions

Albumin-Bound Paclitaxel (1)  ·  Bevacizumab (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  Nivolumab (1)  ·  Oxaliplatin (1)  ·  Taxes (1)  ·  trifluridine tipiracil drug combination (1)

Sponsors

Grupo Espanol de Investigacion en Sarcomas (1)  ·  Immunome, Inc. (1)  ·  Parabilis Medicines, Inc. (1)  ·  Rabin Medical Center (1)

Countries

Australia (2)  ·  Israel (2)  ·  Spain (2)  ·  United States (2)  ·  Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Benjamin Oshrine (1)  ·  Francisco Bautista, MD (1)  ·  Jaume Mora, MD (1)  ·  Javier Martin Broto, MD (1)  ·  Mrinal Gounder, MD (1)

Results publications

PMID 39956770

NIH funding

2016 (1)